The CanScreen5 project provides a tool for monitoring the performance and improving the quality of global cancer screening programs — and highlights the importance of robust quality assurance in this setting.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Romero, Y. et al. Lancet Oncol. 19, e546–e555 (2018).
Dickinson, J. A. et al. Can. Fam. Physician 65, 331–336 (2019).
Zhang, L. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02315-6 (2023).
Lönnberg, S. et al. in European Guide on Quality Improvement in Comprehensive Cancer Control (eds Albreht, T. et al.) Ch. 4, 39–76 (2017).
Mandal, R. & Basu, P. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 61, 1505–1512 (2018).
Noman, S. et al. Int. J. Environ. Res. Public Health 18, 263 (2020).
Sabates, R. & Feinstein, L. Soc. Sci. Med. 62, 2998–3010 (2006).
Alameer, A. et al. J. Cancer Educ. 34, 865–870 (2019).
US Preventive Services Task Force. J. Am. Med. Soc. 325, 962–970 (2021).
Cao, W. et al. EClinicalMedicine 52, 101594 (2022).
Doubeni, C. A. et al. CA Cancer J. Clin. 68, 199–216 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Wang, F., Dong, X. & Li, N. A call to improve the quality of screening programs. Nat Med 29, 1062–1063 (2023). https://doi.org/10.1038/s41591-023-02305-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02305-8
This article is cited by
-
The landscape of cancer research and cancer care in China
Nature Medicine (2023)